Fidelity National Financial Stock Forecast, Price & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fidelity National Financial in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Fidelity National Financial stock.
View analyst ratings for Fidelity National Financial or view top-rated stocks.

Wall Street analysts have given Fidelity National Financial a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Fidelity National Financial wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Fidelity National Financial saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 4,490,000 shares, a decline of 46.2% from the February 28th total of 8,340,000 shares. Based on an average daily trading volume, of 2,170,000 shares, the short-interest ratio is presently 2.1 days. Approximately 1.7% of the company's shares are short sold.
View Fidelity National Financial's Short Interest.

Fidelity National Financial is scheduled to release its next quarterly earnings announcement on Wednesday, April 28th 2021.
View our earnings forecast for Fidelity National Financial.

Fidelity National Financial, Inc. (NYSE:FNF) issued its earnings results on Wednesday, February, 24th. The financial services provider reported $2.01 earnings per share for the quarter, beating the consensus estimate of $1.32 by $0.69. The financial services provider had revenue of $3.77 billion for the quarter, compared to analysts' expectations of $2.97 billion. Fidelity National Financial had a net margin of 10.31% and a trailing twelve-month return on equity of 20.07%. During the same quarter last year, the firm posted $0.95 earnings per share.
View Fidelity National Financial's earnings history.

Fidelity National Financial's stock was trading at $37.47 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, FNF shares have increased by 16.5% and is now trading at $43.66.
View which stocks have been most impacted by COVID-19.

Fidelity National Financial declared a quarterly dividend on Wednesday, February 17th. Shareholders of record on Wednesday, March 17th will be paid a dividend of $0.36 per share on Wednesday, March 31st. This represents a $1.44 dividend on an annualized basis and a dividend yield of 3.30%. The ex-dividend date of this dividend is Tuesday, March 16th.
View Fidelity National Financial's dividend history.

Fidelity National Financial pays an annual dividend of $1.44 per share and currently has a dividend yield of 3.33%. Fidelity National Financial has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strock track record of dividend growth. The dividend payout ratio of Fidelity National Financial is 42.48%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Fidelity National Financial will have a dividend payout ratio of 32.07% next year. This indicates that Fidelity National Financial will be able to sustain or increase its dividend.
View Fidelity National Financial's dividend history.

4 brokerages have issued twelve-month price objectives for Fidelity National Financial's shares. Their forecasts range from $29.00 to $50.00. On average, they expect Fidelity National Financial's stock price to reach $38.75 in the next twelve months. This suggests that the stock has a possible downside of 11.2%.
View analysts' price targets for Fidelity National Financial or view top-rated stocks among Wall Street analysts.

145 employees have rated Fidelity National Financial CEO Raymond R. Quirk on Glassdoor.com. Raymond R. Quirk has an approval rating of 82% among Fidelity National Financial's employees.

Some companies that are related to Fidelity National Financial include Berkshire Hathaway (BRK.B), The Progressive (PGR), The Travelers Companies (TRV), The Allstate (ALL), Cincinnati Financial (CINF), Markel (MKL), Arch Capital Group (ACGL), W. R. Berkley (WRB), CNA Financial (CNA), Erie Indemnity (ERIE), Old Republic International (ORI), First American Financial (FAF), RLI (RLI), The Hanover Insurance Group (THG) and Selective Insurance Group (SIGI).
View all of FNF's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Fidelity National Financial investors own include Intel (INTC), AT&T (T), The Home Depot (HD), Pfizer (PFE), Johnson & Johnson (JNJ), AbbVie (ABBV), Cisco Systems (CSCO), NVIDIA (NVDA), Verizon Communications (VZ) and Chevron (CVX).

Fidelity National Financial trades on the New York Stock Exchange (NYSE) under the ticker symbol "FNF."

Fidelity National Financial's stock is owned by many different retail and institutional investors. Top institutional investors include Confluence Investment Management LLC (0.84%), PhiloSmith Capital Corp (0.04%), Thompson Investment Management Inc. (0.04%), State of Alaska Department of Revenue (0.01%) and Foundations Investment Advisors LLC (0.00%). Company insiders that own Fidelity National Financial stock include Anthony Park, Brent B Bickett, John D Rood, Michael Joseph Nolan, Michael L Gravelle, Peter O Shea Jr, Peter T Sadowski, Raymond R Quirk, Richard N Massey, Roger S Jewkes and Thomas M Hagerty.
View institutional ownership trends for Fidelity National Financial.

FNF stock was sold by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC, and State of Alaska Department of Revenue. Company insiders that have sold Fidelity National Financial company stock in the last year include Michael Joseph Nolan, Michael L Gravelle, Peter O Shea Jr, Peter T Sadowski, Raymond R Quirk, Richard N Massey, and Roger S Jewkes.
View insider buying and selling activity for Fidelity National Financial or view top insider-selling stocks.

FNF stock was purchased by a variety of institutional investors in the last quarter, including PhiloSmith Capital Corp, Foundations Investment Advisors LLC, and Thompson Investment Management Inc..
View insider buying and selling activity for Fidelity National Financial or or view top insider-buying stocks.

Shares of FNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of FNF stock can currently be purchased for approximately $43.66.

Fidelity National Financial has a market capitalization of $12.71 billion and generates $7.93 billion in revenue each year. The financial services provider earns $1.06 billion in net income (profit) each year or $3.39 on an earnings per share basis.

Fidelity National Financial employs 27,058 workers across the globe.

The following companies are subsidiares of Fidelity National Financial: ATM Holdings, Advanced Total Imaging, Aurum Technology, BPG Holdings, Chicago Title Insurance Company, Commerce Velocity, Commissions Inc (CINC), Commonwealth Land Title Insurance Company, Digital Insurance, FGL Holdings, FNTG Holdings, Fidelity National Title Group, Fidelity National Title Insurance Company, First American Heritage Title Co., Go Apply, HomeSeekers.com, Hudson & Marshall, J. Alexander’s Corporation, Lawyers Title Insurance, Lender Processing Services, LoanCare, O'Charley's, Real Geeks, ServiceLink Holdings, SkySlope, T-System, and United Capital Title Insurance.

Fidelity National Financial was founded in 1847.

The official website for Fidelity National Financial is www.fnf.com.

Fidelity National Financial is headquartered at 601 RIVERSIDE AVENUE, JACKSONVILLE FL, 32204.

Fidelity National Financial's mailing address is 601 RIVERSIDE AVENUE, JACKSONVILLE FL, 32204. The financial services provider can be reached via phone at 904-854-8100 or via email at [email protected]